Introduction of Dasafav 20 mg Tablet

• Dasafav 20 mg Tablet is an anti-cancer medicine containing dasatinib as an active ingredient. Dasafav Dasatinib Tablet is used to treat certain types of cancer. Especially Dasafav 20 mg Film-Coated Tablet is used to treat chronic myeloid leukaemia (CML), a type of blood cancer that affects the production of white blood cells. and also used to treat acute lymphoblastic leukemia (ALL), a type of cancer that affects the production of white blood cells in the bone marrow. Dasafav 20 mg belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the action of certain proteins that promote the growth and spread of cancer cells.
  
  Dasafav Dasatinib Tablet may cause some adverse effects, which may include nausea, vomiting, diarrhea, fatigue, muscle and joint pain, and swelling in the hands and feet. More serious side effects, such as bleeding or blood clotting problems, can also occur. Your doctor might check your blood pressure regularly. It is advised to avoid antacid intake within 2 hours of taking this medicine. Dasafav 20 mg Film-Coated Tablet may reduce the number of blood cells in your blood, thereby increasing the susceptibility to infections. Regular blood tests are required to check your blood cells. It is important to talk to your doctor about the potential risks and benefits of taking Dasatinib Tablet.
  
  Before using Anti-leukemia medicine Dasafav, inform your doctor if you have any pre-existing disease such as liver or kidney disease, a weakened immune system, bleeding or blood clot problems, heart disease or low potassium and magnesium levels in the blood, lung disease, or any other medical complications. Additionally, inform your doctor if you are using any prescription or non-prescription medicines, herbal medicines, vitamins, or any other medicines.inform your doctor before taking this Dasafav 20 mg Tablet. Many other medicines can affect, or be affected by, this medicine, so let your healthcare team know all medications you are using. Dasafav 20 mg is not recommended during pregnancy or while breastfeeding. You must avoid driving if you experience dizziness or blurred vision during treatment.
  
  Dasafav 20 mg Film-Coated Tablet can be taken with or without food. It is best to take it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.
  
  Dasafav 20 mg Tablet is not recommended for use in children and adolescents less than 18 years of age, because safety and efficacy have not been clinically established.
  

Uses of Dasafav 20 mg Tablet

• ​​Chronic myeloid leukemia (CML): Dasafav 20 mg Tablet is used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow, characterized by symptoms that may include fatigue, weakness, night sweats, weight loss, bone pain, and an enlarged spleen.
  
  Acute lymphoblastic leukemia (ALL): Anti-leukemia medicine Dasafav is used in the treatment of acute lymphoblastic leukemia (ALL), a type of cancer that affects white blood cells. It is a fast-growing cancer that starts in the bone marrow, characterized by symptoms that may include fatigue, weakness, shortness of breath, easy bruising or bleeding, and frequent infections.
  

Benefits of Dasafav 20 mg Tablet

• ​​Dasatinib Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL.
  
  ​Dasafav Dasatinib Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments.
  
  Dasafav 20 mg is effective in people with CML or ALL who have not responded to other treatments.

Side Effects of Dasafav 20 mg Tablet

• ​Dasafav 20 mg Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects of Dasafav 20 mg Tablet

• • Fever
  • Nausea
  • Nomiting
  • Bleeding
  • Skin rash
  • Diarrhea
  • Infection
  • Bone marrow suppression
  • Pleural effusion
  • Abdominal pain

Common Side Effects of Dasafav 20 mg Tablet

• • Difficulty breathing
    
  • Headache
  • Tiredness
  • Fatigue
  • Muscle and joint pain
  • Swelling in the hands and feet

How to Use Dasafav 20 mg Tablet?

• ​Dasafav 20 mg Film-Coated Tablet may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.

How Dasafav 20 mg Tablet Works?

• ​Dasatinib Tablet belongs to a class of drugs called tyrosine kinase inhibitors, Dasafav 20 mg Tablet works by inhibiting the activity of specific proteins called tyrosine kinases, which play a role in the growth and survival of cancer cells. It inhibits the activity of the BCR-ABL tyrosine kinase, which is a key driver of the abnormal growth of CML and Ph+ ALL cells. By inhibiting the activity of the BCR-ABL tyrosine kinase, Dasafav 20 mg can help to slow down or stop the growth and spread of cancer cells, leading to an improvement in symptoms and potential benefits.

Safety Advices Dasafav 20 mg Tablet

Kidney

Use with Caution

Patients with kidney disease should closely monitor kidney function while taking Dasafav Dasatinib Tablet and report any unusual symptoms or changes in kidney function to their physician. The dose of Dasafav 20 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.

Alcohol

Unsafe

It is generally not recommended to drink alcohol while taking Dasatinib Tablet. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.

Breastfeeding

Unsafe

It is not recommended to breastfeed while taking Dasafav Dasatinib Tablet. Dasafav 20 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Dasafav 20 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.

Driving

Unsafe

Anti-leukemia medicine Dasafav may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Dasafav 20 mg.

Pregnancy

Unsafe

Use of Anti-leukemia medicine Dasafav may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Dasafav 20 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.

Liver

Use with Caution

Dasafav 20 mg Film-Coated Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Dasafav 20 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Anti-leukemia medicine Dasafav may need to be adjusted in patients with liver disease.